ADDF Prevention RFP
Supports dementia prevention research through precision risk reduction, combination treatment testing, and effectiveness comparisons.
Eligibility · Global — open worldwide
The Alzheimer's Drug Discovery Foundation (ADDF) Prevention RFP funds clinical research targeting dementia risk reduction across three distinct categories: precision prevention and risk reduction, combination therapy studies, and comparative effectiveness research. ADDF, founded in 1998 and headquartered in New York, has distributed nearly $400 million to 792 programs in 21 countries and applies a…
Precision prevention, combination therapy studies, and comparative effectiveness research targeting dementia risk reduction. Anti-amyloid strategies and cholinesterase inhibitors excluded.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline